KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Cash from Investing Activities: 2014-2024

Historic Cash from Investing Activities for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$548.4 million.

  • BeOne Medicines' Cash from Investing Activities rose 63.20% to -$49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$331.4 million, marking a year-over-year increase of 35.94%. This contributed to the annual value of -$548.4 million for FY2024, which is 1013.86% down from last year.
  • According to the latest figures from FY2024, BeOne Medicines' Cash from Investing Activities is -$548.4 million, which was down 1,013.86% from $60.0 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Cash from Investing Activities registered a high of $1.1 billion during FY2022, and its lowest value of -$3.2 billion during FY2020.
  • In the last 3 years, BeOne Medicines' Cash from Investing Activities had a median value of $60.0 million in 2023 and averaged $196.3 million.
  • As far as peak fluctuations go, BeOne Medicines' Cash from Investing Activities skyrocketed by 116.11% in 2021, and later tumbled by 1,013.86% in 2024.
  • BeOne Medicines' Cash from Investing Activities (Yearly) stood at -$3.2 billion in 2020, then soared by 116.11% to $510.3 million in 2021, then skyrocketed by 111.06% to $1.1 billion in 2022, then slumped by 94.43% to $60.0 million in 2023, then crashed by 1,013.86% to -$548.4 million in 2024.